CA2339089C - Cold-adapted equine influenza viruses - Google Patents

Cold-adapted equine influenza viruses Download PDF

Info

Publication number
CA2339089C
CA2339089C CA002339089A CA2339089A CA2339089C CA 2339089 C CA2339089 C CA 2339089C CA 002339089 A CA002339089 A CA 002339089A CA 2339089 A CA2339089 A CA 2339089A CA 2339089 C CA2339089 C CA 2339089C
Authority
CA
Canada
Prior art keywords
virus
cold
equine influenza
set forth
influenza virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002339089A
Other languages
English (en)
French (fr)
Other versions
CA2339089A1 (en
Inventor
Patricia W. Dowling
Julius S. Youngner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of CA2339089A1 publication Critical patent/CA2339089A1/en
Application granted granted Critical
Publication of CA2339089C publication Critical patent/CA2339089C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation
    • C12N2760/16164Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002339089A 1998-08-13 1999-08-12 Cold-adapted equine influenza viruses Expired - Lifetime CA2339089C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/133,921 1998-08-13
US09/133,921 US6177082B1 (en) 1998-08-13 1998-08-13 Cold-adapted equine influenza viruses
PCT/US1999/018583 WO2000009702A1 (en) 1998-08-13 1999-08-12 Cold-adapted equine influenza viruses

Publications (2)

Publication Number Publication Date
CA2339089A1 CA2339089A1 (en) 2000-02-24
CA2339089C true CA2339089C (en) 2009-06-02

Family

ID=22460917

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002339089A Expired - Lifetime CA2339089C (en) 1998-08-13 1999-08-12 Cold-adapted equine influenza viruses

Country Status (10)

Country Link
US (3) US6177082B1 (OSRAM)
EP (2) EP1105497B1 (OSRAM)
JP (3) JP4583602B2 (OSRAM)
AT (1) ATE358722T1 (OSRAM)
AU (1) AU760356B2 (OSRAM)
CA (1) CA2339089C (OSRAM)
DE (1) DE69935721T2 (OSRAM)
DK (1) DK1105497T3 (OSRAM)
ES (1) ES2286892T3 (OSRAM)
WO (1) WO2000009702A1 (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711389D0 (en) * 1997-06-04 1997-07-30 Univ Wales The Bacterial pheromones and uses therefor
US6482414B1 (en) 1998-08-13 2002-11-19 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
WO2001074386A2 (en) * 2000-04-03 2001-10-11 The University Of Pittsburgh - Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
ES2526191T3 (es) 2002-04-26 2015-01-08 Medimmune, Llc Método para producir virus influenza B infeccioso en cultivo celular
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
KR101190932B1 (ko) 2003-02-25 2012-10-16 메디뮨 엘엘씨 인플루엔자 백신 조성물의 제조 방법
WO2005014778A2 (en) * 2003-05-15 2005-02-17 The Board Of Regents For Oklahoma State University Dna vaccine expressing ha1 of equine-2 influenza virus
JP4771959B2 (ja) * 2003-12-23 2011-09-14 メディミューン,エルエルシー インフルエンザウイルス作製のための多重プラスミド系
JP2008503939A (ja) * 2004-06-17 2008-02-07 ダブリュー ファイブ ネットワークス インコーポレイテッド 低電力無線通信システム及びプロトコル
US7572620B2 (en) 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
NZ562661A (en) * 2005-04-21 2010-04-30 Univ Florida Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20080241184A1 (en) * 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
BRPI0616328A2 (pt) * 2005-10-07 2011-06-14 Pfizer Prod Inc vacinas e mÉtodos para tratar influenza canino
US7468187B2 (en) * 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use
CA2626489C (en) * 2005-10-19 2020-10-27 University Of Florida Research Foundation, Inc Materials and methods for respiratory disease control in canines
AU2013205112C1 (en) * 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
EP1779866A1 (en) 2005-11-01 2007-05-02 Intervet International BV Prime-boost vaccine for the protection of equines against viral infection
ATE544469T1 (de) * 2005-11-01 2012-02-15 Intervet Int Bv Prime-boost-vakzin zum schutz von pferden vor pferde-influenza
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CA2690196A1 (en) * 2007-06-18 2008-12-24 Medimmune, Llc Influenza b viruses having alterations in the hemaglutinin polypeptide
ES2842595T3 (es) 2011-03-14 2021-07-14 Boehringer Ingelheim Animal Health Usa Inc Vacuna contra la rinitis equina
KR101490292B1 (ko) 2012-04-16 2015-02-04 한국생명공학연구원 신규한 h3n8 말 인플루엔자 바이러스
JP2013099339A (ja) * 2013-01-04 2013-05-23 Wisconsin Alumni Research Foundation H3型ウマa型インフルエンザウイルス
US10080792B2 (en) 2013-09-23 2018-09-25 Engen Bio, Inc. Influenza vaccine and therapy
CN104436157A (zh) 2013-09-23 2015-03-25 恩金生物有限公司 流感疫苗和治疗
CA2967532A1 (en) 2014-11-24 2016-06-02 Intervet International B.V. Inactivated equine influenza virus vaccines
JP2023506304A (ja) 2019-12-18 2023-02-15 インターベット インターナショナル ベー. フェー. 経口呼吸器ワクチン

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3518347A (en) 1965-05-28 1970-06-30 Inst Microbiologie Et D Hygien Vaccine for equine influenza
US3992522A (en) * 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
SE434346C (sv) * 1982-04-07 1985-10-28 Johann Haberl Cyklonavskiljare med filterenhet for avskiljning av stoff fran gas, varvid en veckad filterenhet er anordnad med en ringspalt mot avskiljarens centralror
CA1204069A (en) 1982-04-16 1986-05-06 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
US4683137A (en) 1982-04-16 1987-07-28 Cornell Research Foundation, Inc. Temperature sensitive reassortant viruses and a vaccine against equine influenza
GB8300467D0 (en) 1983-01-08 1983-02-09 Wellcome Found Equine influenza
US4631191A (en) 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
US4920213A (en) 1985-06-20 1990-04-24 Biotechnology Research Partners, Ltd. Method and compositions useful in preventing equine influenza
US5149531A (en) 1990-06-27 1992-09-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
US6177082B1 (en) 1998-08-13 2001-01-23 The University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cold-adapted equine influenza viruses

Also Published As

Publication number Publication date
CA2339089A1 (en) 2000-02-24
US6649169B2 (en) 2003-11-18
US6436408B1 (en) 2002-08-20
AU5487799A (en) 2000-03-06
JP2009297040A (ja) 2009-12-24
DE69935721T2 (de) 2008-02-07
JP2002522078A (ja) 2002-07-23
EP1105497B1 (en) 2007-04-04
DK1105497T3 (da) 2007-07-30
US6177082B1 (en) 2001-01-23
JP5261338B2 (ja) 2013-08-14
AU760356B2 (en) 2003-05-15
EP1854886A2 (en) 2007-11-14
ES2286892T3 (es) 2007-12-01
DE69935721D1 (de) 2007-05-16
ATE358722T1 (de) 2007-04-15
JP2012085657A (ja) 2012-05-10
WO2000009702A1 (en) 2000-02-24
JP4583602B2 (ja) 2010-11-17
EP1105497A1 (en) 2001-06-13
EP1854886A3 (en) 2007-11-21
US20030180322A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
CA2339089C (en) Cold-adapted equine influenza viruses
US7438919B2 (en) Cold-adapted equine influenza viruses
US7399477B2 (en) Cold-adapted equine influenza viruses
US8282937B2 (en) Cold-adapted (CA) reassortant influenza virus
JP2002522078A5 (OSRAM)
KR101466326B1 (ko) 약독화된 인플루엔자 바이러스 및 이를 포함하는 생백신
US7029903B2 (en) Cold-adapted equine influenza viruses
AU2001249300A1 (en) Cold-adapted equine influenza viruses
US20010051161A1 (en) Cold-adapted equine influenza viruses

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190812